Science
NCTalks with Robert Fox: current landscape and potential treatment regimens for ibudilast in MS
2018-05-04
Download
Right click and do "save link as"
Last week we had the pleasure of attending the American Academy of Neurology’s 70th Annual Meeting (April 21–27, CA, USA), where we spoke to Robert Fox, from the Mellen Center for Multiple Sclerosis at the Cleveland Clinic (OH, USA), about the Phase II SPRINT-MS trial of ibudilast in progressive multiple sclerosis.
In this #NCTalks podcast recorded at the event, Lauren Pulling (Publisher) speaks to Robert, who is the Protocol Principal Investigator in the trial, to learn more about the current landscape that led to this research and potential treatment regimens. Listen to our podcast below to find out more.
View more podcasts, news and exclusive interviews at www.neuro-central.com
view more
More Episodes
Reproducibility in microbiomics
2021-03-25
2021-03-25
How can we achieve gender equality in STEM?
2021-03-05
2021-03-05
The importance of bacteriophage collections
2020-11-09
2020-11-09
OCTalks: Comprehensive Genomic Profiling
2020-11-09
2020-11-09
OCTalks: the ethics of COVID-19 and cancer
2020-11-09
2020-11-09
Get this podcast on your
phone, FREE
